Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors
- 6 July 1993
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 238 (1) , 121-125
- https://doi.org/10.1016/0014-2999(93)90515-j
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Pivaloyl-directed regioselective syntheses of 2,3,6-trioxygenated benzamides: phenolic metabolites of remoxiprideThe Journal of Organic Chemistry, 1993
- Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligandEuropean Journal of Pharmacology, 1991
- NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptorsPsychopharmacology, 1991
- Comparison of the In Vitro Receptor Binding Properties of N‐[3H]Methylspiperone and [3H]Raclopride to Rat and Human Brain MembranesJournal of Neurochemistry, 1990
- Clinical profile of remoxipride - a combined analysis of a comparative double-blind multicentre trial programmeActa Psychiatrica Scandinavica, 1990
- Biochemical pharmacology of the atypical neuroleptic remoxiprideActa Psychiatrica Scandinavica, 1990
- Human dopamine receptor subtypes?in vitro binding analysis using3H-SCH 23390 and3H-racloprideJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- Comparison of Neuroleptic Binding Characteristics in Rat Striatum and Renal CortexJournal of Receptor Research, 1988
- Effects of Remoxipride and some Related New Substituted Salicylamides on Rat Brain ReceptorsActa Pharmacologica et Toxicologica, 1986
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980